Literature DB >> 15543189

Argon laser photocoagulation for retinopathy of prematurity: long-term outcome.

L H Ospina1, C J Lyons, C Matsuba, J Jan, A Q McCormick.   

Abstract

PURPOSE: To assess the visual, refractive, ocular structural, and neurodevelopmental outcome in a group of children who were screened, treated with laser photocoagulation for threshold retinopathy of prematurity (ROP), and followed up at our institution.
METHODS: The 21 survivors of a cohort of 23 children were recalled at the age of 5 years or more. They underwent a full ophthalmologic examination. A paediatric neurologist and/or developmental paediatrician performed a neurodevelopmental assessment and a neuropsychologist performed psychological testing.
RESULTS: A total of 30 eyes (71.4%) had a best-corrected visual acuity (BCVA) of 20/40 or better. In all, 26 (62%) eyes were myopic; the overall mean spherical equivalent was -4.95 D. No eye had Stage 4 findings and only one eye (2.4%) progressed to stage 5 despite photocoagulation. In total, 14 patients (66.6%) showed evidence of stereopsis. Strabismus was seen in six patients (28.5%) and nystagmus in three (14.3%). Periventricular leukomalacia (PVL) was identified in five patients (23.8%), cerebral palsy (CP) in seven (33.3%), and intraventricular haemorrhage (IVH) in 13 (62%). Cerebral palsy and IVH associated strongly with visual acuity of less than 20/40 (P=0.009 and 0.047). There was also a strong association between visual acuity of 20/40 or above and a better cognitive outcome (P=0.013).
CONCLUSIONS: Retinal scarring and detachment are relatively rare causes of visual morbidity 5 years or more after laser treatment for threshold ROP, but the neurological sequelae of extreme prematurity and amblyopia remain important causes of impaired visual function.

Entities:  

Mesh:

Year:  2005        PMID: 15543189     DOI: 10.1038/sj.eye.6701729

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Late clinical characteristics of infants with retinopathy of prematurity and treated with cryotherapy.

Authors:  Eren Cerman; Deniz Ozarslan Ozcan; Hande Celiker; Muhsin Eraslan; Ozlem Sahin; Haluk Kazokoglu
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

2.  Refractive and Visual Outcome after Laser-Treated Retinopathy of Prematurity in Western Romania.

Authors:  Florina Stoica; Corina Ladariu; Marie-Jeanne Koos; Alina Stanciu; Gabriela Olariu; Nicoleta Andreescu; Maria Puiu
Journal:  Maedica (Buchar)       Date:  2016-06

3.  Long term visual outcomes in laser treated threshold retinopathy of prematurity in Central Saudi Arabia.

Authors:  Abdullah G Al-Otaibi; Sultan S Aldrees; Ahmed A Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-06-07

4.  Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity.

Authors:  Parag K Shah; Minu Ramakrishnan; Bani Sadat; Sandeep Bachu; V Narendran; N Kalpana
Journal:  Oman J Ophthalmol       Date:  2014-09

Review 5.  Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Authors:  José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob
Journal:  J Neuroinflammation       Date:  2017-08-22       Impact factor: 8.322

Review 6.  New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.

Authors:  Juhee Ryu
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

7.  Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity.

Authors:  Majid Farvardin; Zahra Kalantari; Mohammadreza Talebnejad; Marzieh Alamolhoda; Amir Norouzpour
Journal:  J Ophthalmic Vis Res       Date:  2022-08-15

8.  Refractive outcome of prethreshold retinopathy of prematurity treated by diode laser: follow-up at 5 years.

Authors:  Phuoc Huu Nguyen; Caroline Catt; Tinh Xuan Nguyen; Van Trong Pham
Journal:  Clin Ophthalmol       Date:  2015-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.